Phenanthrenes and derivatives
Electron Microscopy Sciences Rosin Alcoholic Stock Solution 250 ML
Used in Wolbach's Giemsa Method, Wolbach, Todd, and Palfrey (1922) for the staining of : nuclei, collagen, riskettsia and bacteria. See references Wolbach, S.B., Todd, J.L., and Paltrey, F.W., The Etiology of Pathology Typhus, Harvard University Press, Cambridge, MA, p. 13-14, c. 1922 and Luna, L.G., (ed). Manual of Histologic Staining Methods od the AFIP, 3rd edition. McGraw-Hill, NY, p. 119, c. 1968.
Electron Microscopy Sciences Rosin Alcohol Working Solution 500 ML
Used in Wolbach's Giemsa Method Wolbach, Todd, and Palfrey (1922) Nuclei, collagen. References are Wolbach, S.B., Todd, J.L. and Palfrey, F.W., The Etilogy of Pathology Typhus, Harvard University Press, Cambridge, MA., p. 13 – 14,c 1922 and Luna, L.G., (ed), Manual of Histologic Staining Methods of the AFIP, 3rd Edition, McGraw-Hill, Y, p. 119, c. 1968
Chem-Impex International, Inc. 9,10-Phenanthrenequinone | MFCD00001163 | 100G
9,10-Phenanthrenequinone, MFCD00001163, 100G
eMolecules 141-82-2 | Malonic acid anhydrous | Chem-Impex104.061 | C3H4O4 | 99.000 | OC(=O)CC(O)=O | 10kg | 112444175
Malonic acid anhydrous | Chem-Impex | 141-82-2104.061 | C3H4O4 | 99.000 | OC(=O)CC(O)=O | 10kg | 112444175
Crescent Chemical Co Inc CHRYSENE-D12 SOLN 1ML
Chrysene-d12 Single Component Calibration Standard in Dichloromethane CAS 1719-03-5 Size - 1mL Catalog Number - 3689D.10
Apexbio Technology LLC CVT-313 199986-75-9 200mg
CVT-313 (CAS 199986-75-9) is a potent inhibitor of cyclin-dependent kinase 2 (CDK2) an enzyme essential for G1/S transition during cell cycle progression By targeting CDK2 CVT-313 effectively reduces hyperphosphorylation of retinoblastoma protein (Rb) leading to cell cycle arrest at the G1/S boundary In vitro studies with MRC-5 fibroblasts demonstrated significant growth inhibition Additionally CVT-313 induces apoptosis in diffuse large B-cell lymphoma by diminishing phosphorylation of Rb at T821 and downregulating anti-apoptotic protein Mcl-1 In animal models of arterial restenosis CVT-313 significantly reduces neointimal proliferation indicating potential utility for proliferative disorders research
Apexbio Technology LLC Alendronic acid 66376-36-1 200mg
Alendronic acid is a small-molecule inhibitor targeting farnesyl diphosphate synthase (FDPS) It is designed to inhibit FDPS activity thereby disrupting protein prenylation pathways required for osteoclast functionality and regulating osteoclast-mediated bone resorption Alendronic acid exerts its biological activity primarily through inhibition of FDPS which suppresses osteoclast activity and associated bone mineral degradation Based on these pharmacological properties alendronic acid holds research potential in the investigation of bone remodeling mechanisms particularly in the contexts of postmenopausal osteoporosis Paget s disease and tumor-related hypercalcemia
eMolecules 1705-85-7 | 6-Methyl Chrysene | Toronto Research Chemicals | MFCD00215920 | 242.321 | C19H14 | 95.000 | Cc1cc2c3ccccc3ccc2c2ccccc12 | 100mg | 601597882
6-Methyl Chrysene | Toronto Research Chemicals | 1705-85-7 | MFCD00215920 | 242.321 | C19H14 | 95.000 | Cc1cc2c3ccccc3ccc2c2ccccc12 | 100mg | 601597882
eMolecules 789-47-9 | 2-Aminochrysene | Combi-Blocks, Inc. | MFCD00046286 | 243.309 | C18H13N | 97.000 | Nc1ccc2c(ccc3c4ccccc4ccc23)c1 | 1g | 569291100
2-Aminochrysene | Combi-Blocks, Inc. | 789-47-9 | MFCD00046286 | 243.309 | C18H13N | 97.000 | Nc1ccc2c(ccc3c4ccccc4ccc23)c1 | 1g | 569291100